Sr-13668

Sr-13668

SCHEMBL30173443

CCOC(=O)c1ccc2[nH]c3c(OC)c4[nH]c5ccc(C(=O)OCC)cc5c4cc3c2c1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AKT1

The experimentally established mechanism targets of Sr-13668. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.64
ALDH1A1 P00352 7/20 0.64
MAPT P10636 6/20 0.64
MEN1 O00255 4/20 0.64
KMT2A Q03164 4/20 0.64
RAB9A P51151 3/20 0.64
HCRTR1 O43613 2/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
HSD17B10 Q99714 5/20 0.59
HPGD P15428 5/20 0.59
MAPK1 P28482 3/20 0.59
POLB P06746 2/20 0.59
NPC1 O15118 2/20 0.54
TUBB4A P04350 2/20 0.52
TUBB P07437 2/20 0.52
TUBA3C P0DPH7 2/20 0.52
TUBA1B P68363 2/20 0.52
TUBA4A P68366 2/20 0.52
TUBB4B P68371 2/20 0.52
TUBB3 Q13509 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sr-13668 SCHEMBL29381258 1.00 KDM4E (0.64) KDM4EALDH1A1MAPTMEN1KMT2A
Sr-13668 SCHEMBL1071997 1.00 KDM4E (0.64) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL12642105 0.95 KDM4E (0.58) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL18705463 0.94 KDM4E (0.57) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL3199051 0.90 KDM4E (0.64) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL3187981 0.88 HCRTR1 (0.70) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL1120941 0.87 KDM4E (0.61) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL3197990 0.86 KDM4E (0.67) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL12968290 0.86 KDM4E (0.67) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL13535329 0.86 KDM4E (0.60) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119185322-A Tetracyclic quinolone analog combination therapies for treating cancer 生华生物科技股份有限公司 2024-12-27 CN disclosed
CN-119119296-A Allogeneic cell compositions and methods of use 波赛达治疗公司 2024-12-13 CN disclosed
CN-113383018-B Allogeneic cell compositions and methods of use 波赛达治疗公司 2024-09-10 CN disclosed
CN-115697413-A Radiopharmaceuticals and imaging agents targeting FAP and uses related thereto 塔夫茨大学信托人 2023-02-03 CN disclosed